| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/01/24 | 22 : 08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/24 | 22 : 06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/24 | 22 : 01 | GlobeNewswire Inc. | Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage ... | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/24 | 20 : 07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/24 | 20 : 06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/17 | 07 : 32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/17 | 07 : 30 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/15 | 21 : 00 | GlobeNewswire Inc. | Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc. | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/05 | 08 : 05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/05 | 07 : 58 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2019/01/05 | 02 : 08 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/27 | 06 : 12 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/17 | 20 : 15 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/17 | 20 : 15 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/17 | 20 : 10 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/15 | 06 : 49 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/15 | 06 : 47 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/15 | 02 : 30 | GlobeNewswire Inc. | Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/10 | 21 : 00 | GlobeNewswire Inc. | Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018 | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/12/06 | 22 : 08 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/30 | 22 : 02 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/21 | 20 : 01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/21 | 07 : 23 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/21 | 06 : 11 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/17 | 07 : 33 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/17 | 06 : 16 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/17 | 06 : 15 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/01 | 05 : 37 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/01 | 05 : 36 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:APRI | Apricus Biosciences, Inc. |
| 2018/11/01 | 05 : 24 | GlobeNewswire Inc. | Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results | NASDAQ:APRI | Apricus Biosciences, Inc. |